GLP-1 Reduces Recurrent Ischemic Stroke in Type 2 Diabetes đ Access full article via Medscape NeurologyLiraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase in intracranial hemorrhage or mortality. Medscape Medical News Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
